Corticosteroid Use in Patients with Crohn's Disease Initiating Vedolizumab in the Real-World Setting

被引：0
|
作者：
Sands, Bruce [1 ]
Khalid, Javaria [2 ]
Barocas, Morris [3 ]
Raluy-Callado, Mireia [4 ]
Merinopoulou, Evie [4 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Takeda Dev Ctr Europe Ltd, London, England
[3] Takeda Pharmaceut Inc, Deerfield, IL USA
[4] Evidera, London, England
来源：
INFLAMMATORY BOWEL DISEASES | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-064
引用
收藏
页码：S26 / S26
页数：1
相关论文
共 50 条
  • [31] Early Observations in the Real-World Use of Risankizumab Therapy for Crohn's Disease
    Leone, Anna
    Drosdak, Alyssa
    Chiplunker, Adeeti
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S757 - S758
  • [32] REAL WORLD EVALUATION OF PROLONGED CLINICAL RESPONSE WITH VEDOLIZUMAB IN CROHN'S DISEASE AND ULCERATIVE COLITIS PATIENTS TREATED IN A PRIVATE PRACTICE SETTING
    Ritter, Timothy E.
    Fourment, Chris
    Van Anglen, Lucinda J.
    Okoro, Tracy C.
    Hardin, Thomas C.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S74 - S74
  • [33] Upadacitinib in Crohn's Disease Patients: for what type of patients in real world setting ?
    Juillerat, P.
    Martinho-Grueber, M.
    Ruetsch, R.
    Moubayed, H.
    Vulliemoz, M.
    Michetti, P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2059 - I2059
  • [34] Upadacitinib in Crohn's Disease Patients: for what type of patients in real world setting?
    Juillerat, Pascal
    Martinho-Grueber, Maude
    Ruetsch, Roseline
    Moubayed, Hayssam
    Vulliemoz, Marianne
    Michetti, Pierre
    SWISS MEDICAL WEEKLY, 2023, 153 : 26S - 26S
  • [35] REAL WORLD EVALUATION OF PROLONGED CLINICAL RESPONSE WITH VEDOLIZUMAB IN CROHN'S DISEASE AND ULCERATIVE COLITIS PATIENTS TREATED IN A PRIVATE PRACTICE SETTING
    Ritter, Timothy E.
    Fourment, Chris
    Van Anglen, Lucinda J.
    Okoro, Tracy C.
    Hardin, Thomas C.
    GASTROENTEROLOGY, 2018, 154 (01) : S105 - S105
  • [36] Upadacitinib in Crohn's disease: real-world experience
    Mir, Adil S.
    MINERVA GASTROENTEROLOGY, 2024, 70 (04): : 442 - 445
  • [37] Colombian real-world experience of vedolizumab use in patients with inflammatory bowel disease-EXVEDOCOL
    Parra Izquierdo, V.
    Cifuentes Amortegui, S.
    Avendano R, S.
    Ponce de Leon, E.
    Florez, C.
    Reyes Medina, G.
    Puentes M, F. E.
    Ballesteros B, M.
    Nunez, E. E.
    Hemandez, M.
    Kock, J.
    Marquez, J. R.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S181 - S182
  • [38] CORTICOSTEROID DOSE REDUCTION WITH VEDOLIZUMAB TREATMENT OF CROHN'S DISEASE
    Loftus, E.
    Siegel, C.
    Panaccione, R.
    Sandborn, W.
    Smyth, M.
    James, A.
    Xu, J.
    Abhyankar, B.
    GUT, 2016, 65 : A147 - A147
  • [39] The Use of Vedolizumab in Patients with Concomitant Cirrhosis and Crohn's Disease
    Kapila, Nikhil
    Flocco, Gianina
    Shen, Bo
    Esfeh, Jamak Modaresi
    CUREUS, 2018, 10 (07):
  • [40] Real-world experience of vedolizumab use in Colombian patients with inflammatory bowel disease--EXVEDOCOL
    Parra, Viviana
    Cifuentes, Sandra
    Avendano, Sandra
    de Leon, Enrique Ponce
    Florez, Cristian
    Reyes, Gustavo
    Puentes, Fabian
    Ballesteros, Manuel
    Nunez, Edilberto
    Gomez, Federico
    Marquez, Juan Ricardo
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2024, 47 (08): : 858 - 866
12345